학술논문
Defining the scope of the European Antimicrobial Resistance Surveillance network in Veterinary medicine (EARS-Vet): a bottom-up and One Health approach.
Document Type
Academic Journal
Author
Mader R; University of Lyon, French Agency for Food, Environmental and Occupational Health and Safety (ANSES), Laboratory of Lyon, Antibiotic Resistance and Bacterial Virulence Unit, 31 Avenue Tony Garnier, 69007 Lyon, France.; Bourély C; Direction générale de l'alimentation, Bureau de la santé animale, 75015 Paris, France.; Amat JP; University of Lyon, French Agency for Food, Environmental and Occupational Health and Safety (ANSES), Laboratory of Lyon, Epidemiology and Support to Surveillance Unit, 31 avenue Tony Garnier, 69007 Lyon, France.; Broens EM; Utrecht University, Faculty of Veterinary Medicine, Department of Biomolecular Health Sciences, Yalelaan 1, 3584 CL Utrecht, The Netherlands.; Busani L; Istituto Superiore di Sanità, Center for Gender-Specific Medicine, Viale Regina Elena 299, 00161 Rome, Italy.; Callens B; Antimicrobial Consumption and Resistance in Animals-AMCRA, Galileelaan 5/02, 1210 Brussels, Belgium.; Crespo-Robledo P; Agencia Española del Medicamento y Productos Sanitarios (AEMPS), Coordinación del Plan Nacional Antibióticos (PRAN), calle Campezo 1, EDF. 8. 28022 Madrid, España.; Damborg P; University of Copenhagen, Department of Veterinary and Animal Sciences, Stigbøjlen 4, 1870 Frederiksberg C, Denmark.; Filippitzi ME; Sciensano, Veterinary Epidemiology Unit, Belgian Research Centre for Health, Rue Juliette Wytsmanstraat 14, 1050 Brussels, Belgium.; Laboratory of Economics of Animal Production, Faculty of Veterinary Medicine, Aristotle University of Thessaloniki, 54124, Greece.; Fitzgerald W; Limerick Regional Veterinary Laboratory, Department of Agriculture, Food and the Marine, Knockalisheen, Limerick V94 WK44, Ireland.; Grönthal T; University of Helsinki, Department of Equine and Small Animal Medicine, Viikintie 49, 00790 Helsinki, Finland.; Haenni M; University of Lyon, French Agency for Food, Environmental and Occupational Health and Safety (ANSES), Laboratory of Lyon, Antibiotic Resistance and Bacterial Virulence Unit, 31 Avenue Tony Garnier, 69007 Lyon, France.; Heuvelink A; Royal GD, Arnsbergstraat 7, 7418 EZ Deventer, The Netherlands.; van Hout J; Royal GD, Arnsbergstraat 7, 7418 EZ Deventer, The Netherlands.; Kaspar H; Federal Office of Consumer Protection and Food Safety, Mauerstrasse 39-42, 10117 Berlin, Germany.; Muñoz Madero C; Agencia Española del Medicamento y Productos Sanitarios (AEMPS), Coordinación del Plan Nacional Antibióticos (PRAN), calle Campezo 1, EDF. 8. 28022 Madrid, España.; Norström M; Norwegian Veterinary Institute (NVI), Pb 64, N-1431 Ås, Norway.; Pedersen K; National Veterinary Institute, Department of Animal Health and Antimicrobial Strategies, Ulls väg 2B, SE-751 89 Uppsala, Sweden.; Pokludova L; Institute for State Control of Veterinary Biologicals and Medicines (ISCVBM), Hudcova 56 A, Brno, The Czech Republic.; Dal Pozzo F; Antimicrobial Consumption and Resistance in Animals-AMCRA, Galileelaan 5/02, 1210 Brussels, Belgium.; Slowey R; Department of Agriculture, Food and the Marine Laboratories, Backweston, Celbridge, Co. Kildare W23 VW2C, Ireland.; Urdahl AM; Norwegian Veterinary Institute (NVI), Pb 64, N-1431 Ås, Norway.; Vatopoulos A; University of West Attica, Department of Public Health Policy, School of Public Health, Athens, Greece.; Zafeiridis C; Ministry of Rural Development and Food, 2 Acharnon St., Athens, Greece.; Madec JY; University of Lyon, French Agency for Food, Environmental and Occupational Health and Safety (ANSES), Laboratory of Lyon, Antibiotic Resistance and Bacterial Virulence Unit, 31 Avenue Tony Garnier, 69007 Lyon, France.
Source
Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE
Subject
Language
English
Abstract
Background: Building the European Antimicrobial Resistance Surveillance network in Veterinary medicine (EARS-Vet) was proposed to strengthen the European One Health antimicrobial resistance (AMR) surveillance approach.
Objectives: To define the combinations of animal species/production types/age categories/bacterial species/specimens/antimicrobials to be monitored in EARS-Vet.
Methods: The EARS-Vet scope was defined by consensus between 26 European experts. Decisions were guided by a survey of the combinations that are relevant and feasible to monitor in diseased animals in 13 European countries (bottom-up approach). Experts also considered the One Health approach and the need for EARS-Vet to complement existing European AMR monitoring systems coordinated by the ECDC and the European Food Safety Authority (EFSA).
Results: EARS-Vet plans to monitor AMR in six animal species [cattle, swine, chickens (broilers and laying hens), turkeys, cats and dogs], for 11 bacterial species (Escherichia coli, Klebsiella pneumoniae, Mannheimia haemolytica, Pasteurella multocida, Actinobacillus pleuropneumoniae, Staphylococcus aureus, Staphylococcus pseudintermedius, Staphylococcus hyicus, Streptococcus uberis, Streptococcus dysgalactiae and Streptococcus suis). Relevant antimicrobials for their treatment were selected (e.g. tetracyclines) and complemented with antimicrobials of more specific public health interest (e.g. carbapenems). Molecular data detecting the presence of ESBLs, AmpC cephalosporinases and methicillin resistance shall be collected too.
Conclusions: A preliminary EARS-Vet scope was defined, with the potential to fill important AMR monitoring gaps in the animal sector in Europe. It should be reviewed and expanded as the epidemiology of AMR changes, more countries participate and national monitoring capacities improve.
(© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.)
Objectives: To define the combinations of animal species/production types/age categories/bacterial species/specimens/antimicrobials to be monitored in EARS-Vet.
Methods: The EARS-Vet scope was defined by consensus between 26 European experts. Decisions were guided by a survey of the combinations that are relevant and feasible to monitor in diseased animals in 13 European countries (bottom-up approach). Experts also considered the One Health approach and the need for EARS-Vet to complement existing European AMR monitoring systems coordinated by the ECDC and the European Food Safety Authority (EFSA).
Results: EARS-Vet plans to monitor AMR in six animal species [cattle, swine, chickens (broilers and laying hens), turkeys, cats and dogs], for 11 bacterial species (Escherichia coli, Klebsiella pneumoniae, Mannheimia haemolytica, Pasteurella multocida, Actinobacillus pleuropneumoniae, Staphylococcus aureus, Staphylococcus pseudintermedius, Staphylococcus hyicus, Streptococcus uberis, Streptococcus dysgalactiae and Streptococcus suis). Relevant antimicrobials for their treatment were selected (e.g. tetracyclines) and complemented with antimicrobials of more specific public health interest (e.g. carbapenems). Molecular data detecting the presence of ESBLs, AmpC cephalosporinases and methicillin resistance shall be collected too.
Conclusions: A preliminary EARS-Vet scope was defined, with the potential to fill important AMR monitoring gaps in the animal sector in Europe. It should be reviewed and expanded as the epidemiology of AMR changes, more countries participate and national monitoring capacities improve.
(© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.)